(Q34767574)

4 August 2017

1 reference

title

Medical therapy for benign prostatic hyperplasia progression (English)

1 reference

4 August 2017

main subject

prostatic hypertrophy

1 reference

Kevin T McVary

1

1 reference

4 August 2017

publication date

1 August 2002

1 reference

4 August 2017

published in

Current urology reports

1 reference

4 August 2017

volume

3

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

269-275

1 reference

Selective alpha 1-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience

4 August 2017

cites work

1 reference

12 December 2020

High prevalence of benign prostatic hypertrophy in the community

1 reference

12 December 2020

THE INCIDENCE OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATIC CARCINOMA IN CIRRHOSIS OF THE LIVER.

1 reference

12 December 2020

The incidence of benign prostatic obstruction

1 reference

12 December 2020

Trial without catheter following acute retention of urine

1 reference

12 December 2020

Long-term evaluation of tamsulosin in benign prostatic hyperplasia: placebo-controlled, double-blind extension of phase III trial. Tamsulosin Investigator Group

1 reference

12 December 2020

Identification of the poor risk patient with "prostatism" and detrusor failure

1 reference

12 December 2020

Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia

1 reference

12 December 2020

Post-natal growth changes in the human prostate.

1 reference

12 December 2020

The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group.

1 reference

12 December 2020

Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia. PLESS Study Group. Proscar Long-term Efficacy and Safety Study.

1 reference

12 December 2020

Benign prostatic hyperplasia treated by castration or the LH-RH analogue buserelin: a report on 6 cases

1 reference

12 December 2020

The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

12 December 2020

Natural history of prostatism: risk factors for acute urinary retention

1 reference

12 December 2020

Calcium channel antagonists prevent urinary bladder growth and neuroplasticity following mechanical stress

1 reference

12 December 2020

Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia

1 reference

12 December 2020

Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group

1 reference

12 December 2020

Symptoms and signs of prostatism as risk factors for prostatectomy

1 reference

12 December 2020

A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia. United States 93-01 Study Group

1 reference

12 December 2020

The Natural History of Untreated “Prostatism”

1 reference

12 December 2020

Natural history of prostatism: urinary flow rates in a community-based study

1 reference

12 December 2020

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

1 reference

12 December 2020

The development of human benign prostatic hyperplasia with age

1 reference

12 December 2020

Androgen metabolism in men receiving finasteride before prostatectomy

1 reference

12 December 2020

A Dose Titration Study Evaluating Terazosin, a Selective, Once-a-Day α 1-Blocker for the Treatment of Symptomatic Benign Prostatic Hyperplasia

1 reference

12 December 2020

Relationship between bladder morphology and long-term outcome of treatment in patients with high pressure chronic retention of urine

1 reference

12 December 2020

The effect of orchiectomy and estrogens of benign prostatic hyperplasia

1 reference

12 December 2020

American Urological Association symptom index for women with voiding symptoms: lack of index specificity for benign prostate hyperplasia

1 reference

12 December 2020

The use of alpha-adrenergic blockers in benign prostatic obstruction

1 reference

12 December 2020

Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: a multicenter study

1 reference

12 December 2020

Obstructive uropathy in patients with benign prostatic hyperplasia

1 reference

12 December 2020

5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study

1 reference

12 December 2020

Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter study

1 reference

12 December 2020

The prevalence of prostatism: a population-based survey of urinary symptoms

1 reference

12 December 2020

Specificity of the American Urological Association voiding symptom index: comparison of unselected and selected samples of both sexes

1 reference

12 December 2020

Prevalence of Prostatism in Japanese Men in a Community-based Study with Comparison to a Similar American Study

1 reference

12 December 2020

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

12 December 2020

Benign prostatic hyperplasia. The scope of the problem

1 reference

12 December 2020

The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study

1 reference

12 December 2020

10.1007/S11934-002-0047-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1024706044

0 references

1 reference